Evogene GAAP EPS of -$0.06 beats by $0.66, revenue of $1.61M misses by $2.02M

Stock Information for Evogene Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Evogene Ltd.

Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
Evogene Reports First Quarter 2025 Financial Results
Evogene Schedules First Quarter 2025 Financial Results Release
ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio
Evogene Reports Fourth Quarter and Full Year 2024 Financial Results
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025
Evogene Schedules Fourth Quarter 2024 Financial Results Release
AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.